EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking Studies of Rifampicin – rpoB complex: Repurposing Drug Design Implications for against Plasmodium falciparum Malaria through a Computational Approach

Upasana Yadav, Jaya Pandey

Drug Research · 01.03.2023 · 73 (03) · 164-169

DOI: 10.1055/a-1974-9028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.03.2023. Verfasst von Upasana Yadav und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amity School of Applied Sciences Lucknow, Amity University Uttar Pradesh, Lucknow, India. Hauptthemen laut MEDLINE: Malaria, Falciparum, Mycobacterium tuberculosis, Malaria, Antimalarials. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria is one of the world’s most devastating diseases, infecting well over 300 million people annually and killing between 2 and 3 million worldwide. Increasing parasite resistance to many existing drugs is exacerbating disease. Resistance to commonly used malarial drugs is increasing the need to develop new drugs urgently. Due to the slow pace and substantial costs of new drug development, repurposing of old drugs which is recently increasingly becoming an attractive proposition of highly efficient and effective way of drug discovery led us to study the drug rifampicin for this purpose. The present paper aims to investigate the route of Plasmodium falciparum apicoplast-targeted proteins that putatively encode β subunits of RNA polymerase with an objective to develop an effective antimalarial drug. Homology searching for conserved binding site to the rifampicin drug and the functional analysis of rpoB gene were done. Multiple Sequence alignment analysis of rpoB was compared with that in E.coli – rpoB and M. tuberculosis – rpoB. Docking studies of Rifampicin – rpoB complex was also done for finding binding affinity. The results of computational studies showed that rifampicin is a potential drug for malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, FalciparumMycobacterium tuberculosisMalariaAntimalarialsHumansRifampinMolecular Docking SimulationDrug RepositioningPlasmodium falciparumDrug Design

Substanzen

RifampinAntimalarials

Autor:innen und Institutionen

  • Amity School of Applied Sciences Lucknow, Amity University Uttar Pradesh, Lucknow, India.

Zitieren

APA

Yadav, U., & Pandey, J. (2023). Molecular Docking Studies of Rifampicin – rpoB complex: Repurposing Drug Design Implications for against Plasmodium falciparum Malaria through a Computational Approach. Drug Research, 73(03), 164-169. https://doi.org/10.1055/a-1974-9028

Vancouver

Yadav U, Pandey J. Molecular Docking Studies of Rifampicin – rpoB complex: Repurposing Drug Design Implications for against Plasmodium falciparum Malaria through a Computational Approach. Drug Research. 2023;73(03):164-169. doi:10.1055/a-1974-9028

BibTeX
@article{Yadav2023,
  author = {Yadav, Upasana and Pandey, Jaya},
  title = {Molecular Docking Studies of Rifampicin – rpoB complex: Repurposing Drug Design Implications for against Plasmodium falciparum Malaria through a Computational Approach},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {03},
  pages = {164--169},
  doi = {10.1055/a-1974-9028}
}
Kostenlos starten →